Adverse Event Reporting News - FDA questions Lilly’s data on Zyprexa
Monday, January 5th, 2009FDA is examining whether Eli Lilly & Company provided it with accurate data about the side effects of the antipsychotic drug Zyprexa, a potent medicine that has been linked to weight gain and diabetes, “The New York Ti…
